Insider Holders & Insider Ownership - REGENERON PHARMACEUTICALS INC. (REGN)

List of insiders holdings for REGENERON PHARMACEUTICALS INC.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
YANCOPOULOS GEORGE
Bd. Co-Chair, President & CSO
2024-02-20 16:03:46801,608
465,370
1,266,978Form 4
SCHLEIFER LEONARD S
Bd. Co-Chair, President & CEO
2023-12-13 16:05:34374,429
320,901
695,330Form 4
VAGELOS P ROY
Director
2023-04-05 16:02:23312,578
154,526
467,104Form 4
SANOFI-AVENTIS
Sanofi-Aventis Amerique du Nord S.N.C.
10% Owner
2020-06-17 17:10:15279,766
0
279,766Form 13D
Sanofi
10% Owner
2020-06-17 17:10:15279,766
0
279,766Form 13D
GOLDBERG MURRAY A
SVP Administration & Asst Secr
2014-12-18 16:25:06142,515
6400
148,915Form 4
RUPP RANDALL
SVP, Manufuring Operations
2007-04-17 14:25:18142,137
0
142,137Form 4
MURPHY ANDREW J
EVP Research
2024-03-15 16:01:0268,306
4310
72,616Form 4
ROBERTS WILLIAM
VP Reg Dev & Med Safety
2014-02-06 16:41:1816,644
55,634
72,278Form 5
GULER HANS PETER
VP Clinical Programs
2004-10-12 12:02:0867,152
0
67,152Form 4
STAHL NEIL
EVP Research and Development
2024-02-28 16:04:0550,999
10,439
61,438Form 4
LAROSA JOSEPH J
EVP General Counsel and Secret
2024-02-28 16:04:4836,543
3722
40,265Form 4
Landry Robert E
EVP Finance CFO
2024-02-06 16:08:1735,480
270
35,750Form 4
Powchik Peter
SVP Clinical Development & Reg
2016-12-19 16:15:0630,714
4133
34,847Form 4
Van Plew Daniel P
EVP & General Mgr, Industrial
2024-02-16 16:15:3220,378
13,460
33,838Form 4
SING GEORGE L
Director
2024-02-28 16:04:1931,687
2150
33,837Form 4
Terifay Robert J
EVP Commercial
2017-12-13 16:52:2932,300
0
32,300Form 4
Fenimore Christopher R.
SVP Finance & CFO
2024-02-12 16:02:0214,372
10,059
24,431Form 4
Dworkin Peter
VP Investor Relations & Commun
2009-12-22 11:21:1323,500
0
23,500Form 4
SHOOTER ERIC M
Director
2014-02-13 19:38:0915,000
5085
20,085Form 4
KOLINSKI STUART
SVP General Counsel and Secret
2010-06-07 16:14:1016,329
3710
20,039Form 4
Aberman Michael S
SVP Strategy Investor Relation
2017-06-23 16:10:087693
12,253
19,946Form 4
RYAN ARTHUR F
Director
2024-03-05 16:01:4918,282
0
18,282Form 4
Pitofsky Jason
Vice President, Controller
2024-02-08 16:01:2115,816
0
15,816Form 3
INGRAM ROBERT ALEXANDER
Director
2015-05-27 16:02:3514,833
0
14,833Form 4
BROWN MICHAEL S
Director
2024-01-04 16:06:092989
11,162
14,151Form 4
McCourt Marion
EVP Commercial
2024-03-05 16:01:3513,431
158
13,589Form 4
McCorkle Douglas S
VP Controller and Asst Treasur
2015-12-29 19:44:106866
4129
10,995Form 4
GILMAN ALFRED G
Director
2015-08-07 18:15:048912
0
8912Form 4
BAKER CHARLES A
Director
2018-01-03 16:14:217439
0
7439Form 4
GOLDSTEIN JOSEPH L
Director
2024-01-25 16:18:366382
0
6382Form 4
Tessier-Lavigne Marc
Director
2023-01-05 16:16:354363
0
4363Form 4
POON CHRISTINE A
Director
2024-01-04 16:10:073779
0
3779Form 4
COLES N ANTHONY
Director
2024-01-04 16:11:273000
0
3000Form 4
Zoghbi Huda Y
Director
2024-01-04 16:11:182989
0
2989Form 4
Thompson Craig B.
Director
2024-01-04 16:15:452061
0
2061Form 4
Bassler Bonnie L
Director
2024-02-26 16:07:531382
0
1382Form 4
Schenkein David P
Director
2024-01-04 16:17:15790
0
790Form 4
Guarini Kathryn
Director
2024-01-04 16:16:40790
0
790Form 4
NOVARTIS PHARMA AG
10% Owner
2005-11-10 14:56:080
0
0Form 13G